title: Requirements of circulatory support during liver transplantation: are patients with familial amyloidosis different from other patients?
authors.affiliation: Department of Transplantation and Department of Anaesthesiology, University Hospitals of Coimbra, Coimbra, Portugal. jvviana@huc.min-saude.pt
authors.forename: J S
authors.initials: JS
authors.lastname: Viana
authors.forename: C
authors.initials: C
authors.lastname: Bento
authors.forename: H
authors.initials: H
authors.lastname: Vieira
authors.forename: S
authors.initials: S
authors.lastname: Neves
authors.forename: C
authors.initials: C
authors.lastname: Seco
authors.forename: R
authors.initials: R
authors.lastname: Perdigoto
authors.forename: A L
authors.initials: AL
authors.lastname: Craveiro
authors.forename: L
authors.initials: L
authors.lastname: Furtado
mesh_terms: D000328:Adult; D017772:Amyloid Neuropathies / Q000601:surgery*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004280:Dobutamine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007430:Intraoperative Care; D008102:Liver Circulation; D016031:Liver Transplantation / Q000379:methods* / Q000502:physiology; D008297:Male; D010656:Phenylephrine / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010656:Phenylephrine; D004280:Dobutamine